The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
Open accessAbstract
Purpose: To review the impact of collaborative studies on advances in the biology and treatment of acute lymphoblastic leukemia (ALL) in children and adolescents. Methods: A review of English literature on childhood ALL focusing on collaborative studies was performed. The resulting article was reviewed and revised by the committee chairs of the major ALL study groups. Results: With long-term survival rates for ALL approaching 90% and the advent of high-resolution genome-wide analyses, several international study groups or consortia were established to conduct collaborative research to further improve outcome. As a result, treatment strategies have been improved for several subtypes of ALL, such as infant, MLL-rearranged, Philadelphia chromosome–positive, and Philadelphia chromosome–like ALL. Many recurrent genetic abnormalities that respond to tyrosine kinase inhibitors and multiple genetic determinants of drug resistance and toxicities have been identified to help develop targeted therapy. Several genetic polymorphisms have been recognized that show susceptibility to developing ALL and that help explain the racial/ethnic differences in the incidence of ALL. Conclusion: The information gained from collaborative studies has helped decipher the heterogeneity of ALL to help improve personalized treatment, which will further advance the current high cure rate and the quality of life for children and adolescents with ALL.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia
Mullighan, C. G., Goorha, S., Radtke, I., Miller, C. B., Coustan-Smith, E., Dalton, J. D., Girtman, K., Mathew, S., Ma, J., Pounds, S. B., et al. (2007) · Nature · doi:10.1038/nature05690 · Cited by 1,801
Self-citationThe genetic basis of early T-cell precursor acute lymphoblastic leukaemia
Zhang, J., Ding, L., Holmfeldt, L., Wu, G., Heatley, S. L., Payne-Turner, D., Easton, J., Chen, X., Wang, J., Rusch, M., et al. (2012) · Nature · doi:10.1038/nature10725 · Cited by 1,596 · cited 1×
“and Ras signaling (eg, IL7R, NRAS, KRAS), and chromatin modification (eg, the polycomb repressor complex 2 and SETD2).(58) Moreover, human ETP ALL cells(58) and a mouse model of Il7r-mutant ETP ALL(59)”
BackgroundSelf-citationDeletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia
Mullighan, C. G., Su, X., Zhang, J., Radtke, I., Phillips, L. A. A., Miller, C. B., Ma, J., Liu, W., Cheng, C., Schulman, B. A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808253 · Cited by 1,422 · cited 4×
“In 2009, two groups of investigators using a different gene expression profiling approach identified a subtype of high-risk B ALL that lacked a known chromosomal rearrangement but exhibited a gene expression profile similar to that of Ph-positive ALL with deletions and, less commonly, sequence mutations of IKZF1.(35,3…”
BackgroundInfluentialSelf-citationTargetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
Roberts, K. G., Li, Y., Payne-Turner, D., Harvey, R. C., Yang, Y.-L., Pei, D., McCastlain, K., Ding, L., Lu, C., Song, G., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1403088 · Cited by 1,377
Self-citationHunger, S. P., Lu, X., Devidas, M., Camitta, B. M., Gaynon, P. S., Winick, N. J., Reaman, G. H., & Carroll, W. L. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.8018 · Cited by 1,180
Self-citationEarly T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia
Coustan-Smith, E., Mullighan, C. G., Onciu, M., Behm, F. G., Raimondi, S. C., Pei, D., Cheng, C., Su, X., Rubnitz, J. E., Basso, G., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70314-0 · Cited by 1,019
Self-citationDen Boer, M. L., van Slegtenhorst, M., De Menezes, R. X., Cheok, M. H., Buijs-Gladdines, J. G., Peters, S. T., Van Zutven, L. J., Beverloo, H. B., Van der Spek, P. J., Escherich, G., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70339-5 · Cited by 930
Self-citationConter, V., Bartram, C. R., Valsecchi, M. G., Schrauder, A., Panzer-Grümayer, R., Möricke, A., Aricò, M., Zimmermann, M., Mann, G., De Rossi, G., et al. (2010) · Blood · doi:10.1182/blood-2009-10-248146 · Cited by 785
Self-citationRelling, M. V., Hancock, M. L., Rivera, G. K., Sandlund, J. T., Ribeiro, R. C., Krynetski, E. Y., Pui, C.-H., & Evans, W. E. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.23.2001 · Cited by 733
Self-citationThe genomic landscape of hypodiploid acute lymphoblastic leukemia
Holmfeldt, L., Wei, L., Diaz-Flores, E., Walsh, M., Zhang, J., Ding, L., Payne-Turner, D., Churchman, M., Andersson, A., Chen, S.-C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2532 · Cited by 731
Self-citationRoberts, K. G., Morin, R. D., Zhang, J., Hirst, M., Zhao, Y., Su, X., Chen, S.-C., Payne-Turner, D., Churchman, M. L., Harvey, R. C., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.06.005 · Cited by 714
Self-citationPieters, R., Schrappe, M., De Lorenzo, P., Hann, I., De Rossi, G., Felice, M., Hovi, L., LeBlanc, T., Szczepanski, T., Ferster, A., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61126-x · Cited by 652
Self-citationGenetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia
Lennard, L., Lilleyman, J. S., Van Loon, J., & Weinshilboum, R. M. (1990) · The Lancet · doi:10.1016/0140-6736(90)91745-v · Cited by 651
Holleman, A., Cheok, M. H., den Boer, M. L., Yang, W., Veerman, A. J. P., Kazemier, K. M., Pei, D., Cheng, C., Pui, C.-H., Relling, M. V., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033513 · Cited by 633
Self-citationRearrangement of CRLF2 in B-progenitor– and Down syndrome–associated acute lymphoblastic leukemia
Mullighan, C. G., Collins-Underwood, J. R., Phillips, L. A. A., Loudin, M. G., Liu, W., Zhang, J., Ma, J., Coustan-Smith, E., Harvey, R. C., Willman, C. L., et al. (2009) · Nature Genetics · doi:10.1038/ng.469 · Cited by 623
Self-citationBoissel, N., Auclerc, M.-F., Lhéritier, V., Perel, Y., Thomas, X., Leblanc, T., Rousselot, P., Cayuela, J.-M., Gabert, J., Fegueux, N., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.053 · Cited by 608
Self-citationOutcome of Treatment in Children with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
Aricò, M., Valsecchi, M. G., Camitta, B., Schrappe, M., Chessells, J., Baruchel, A., Gaynon, P., Silverman, L., Janka-Schaub, G., Kamps, W., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004063421402 · Cited by 600
Self-citationL‐asparaginase treatment in acute lymphoblastic leukemia: A focus on Erwinia asparaginase
Pieters, R., Hunger, S. P., Boos, J., Rizzari, C., Silverman, L., Baruchel, A., Goekbuget, N., Schrappe, M., & Pui, C. (2011) · Cancer · doi:10.1002/cncr.25489 · Cited by 569 · cited 1×
“In one review, intensive use of asparaginase during the intensification phase of therapy was credited for improved outcome.(27) Two studies showed improved outcome with therapeutic drug monitoring during Escherichia coli asparaginase treatment; detection of silent inactivation of the drug as a result of asparaginase a…”
ResultSelf-citationJAK mutations in high-risk childhood acute lymphoblastic leukemia
Mullighan, C. G., Zhang, J., Harvey, R. C., Collins-Underwood, J. R., Schulman, B. A., Phillips, L. A., Tasian, S. K., Loh, M. L., Su, X., Liu, W., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811761106 · Cited by 562
Self-citationStock, W., La, M., Sanford, B., Bloomfield, C. D., Vardiman, J. W., Gaynon, P., Larson, R. A., & Nachman, J. (2008) · Blood · doi:10.1182/blood-2008-01-130237 · Cited by 534
Möricke, A., Zimmermann, M., Reiter, A., Henze, G., Schrauder, A., Gadner, H., Ludwig, W. D., Ritter, J., Harbott, J., Mann, G., et al. (2010) · Leukemia · doi:10.1038/leu.2009.257 · Cited by 520
Self-citationGermline genomic variants associated with childhood acute lymphoblastic leukemia
Treviño, L. R., Yang, W., French, D., Hunger, S. P., Carroll, W. L., Devidas, M., Willman, C., Neale, G., Downing, J., Raimondi, S. C., et al. (2009) · Nature Genetics · doi:10.1038/ng.432 · Cited by 502
Self-citationRussell, L. J., Capasso, M., Vater, I., Akasaka, T., Bernard, O. A., Calasanz, M. J., Chandrasekaran, T., Chapiro, E., Gesk, S., Griffiths, M., et al. (2009) · Blood · doi:10.1182/blood-2009-03-208397 · Cited by 498
Papaemmanuil, E., Hosking, F. J., Vijayakrishnan, J., Price, A., Olver, B., Sheridan, E., Kinsey, S. E., Lightfoot, T., Roman, E., Irving, J. A. E., et al. (2009) · Nature Genetics · doi:10.1038/ng.430 · Cited by 482
Schultz, K. R., Carroll, A., Heerema, N. A., Bowman, W. P., Aledo, A., Slayton, W. B., Sather, H., Devidas, M., Zheng, H. W., Davies, S. M., et al. (2014) · Leukemia · doi:10.1038/leu.2014.30 · Cited by 447
Self-citationYang, J. J., Landier, W., Yang, W., Liu, C., Hageman, L., Cheng, C., Pei, D., Chen, Y., Crews, K. R., Kornegay, N., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.4671 · Cited by 445
Self-citationSchrappe, M., Valsecchi, M. G., Bartram, C. R., Schrauder, A., Panzer-Grümayer, R., Möricke, A., Parasole, R., Zimmermann, M., Dworzak, M., Buldini, B., et al. (2011) · Blood · doi:10.1182/blood-2011-03-338707 · Cited by 435
Self-citationMethotrexate-Induced Neurotoxicity and Leukoencephalopathy in Childhood Acute Lymphoblastic Leukemia
Bhojwani, D., Sabin, N. D., Pei, D., Yang, J. J., Khan, R. B., Panetta, J. C., Krull, K. R., Inaba, H., Rubnitz, J. E., Metzger, M. L., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.0808 · Cited by 400
Self-citationEvans, W. E., Hon, Y. Y., Bomgaars, L., Coutre, S., Holdsworth, M., Janco, R., Kalwinsky, D., Keller, F., Khatib, Z., Margolin, J., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.8.2293 · Cited by 400
Self-citationPui, C.-H., Gaynon, P. S., Boyett, J. M., Chessells, J. M., Baruchel, A., Kamps, W., Silverman, L. B., Biondi, A., Harms, D. O., Vilmer, E., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08782-2 · Cited by 399
Self-citationHomminga, I., Pieters, R., Langerak, A. W., de Rooi, J. J., Stubbs, A., Verstegen, M., Vuerhard, M., Buijs-Gladdines, J., Kooi, C., Klous, P., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.02.008 · Cited by 384
Self-citationThe Pediatric Cancer Genome Project
Downing, J. R., Wilson, R. K., Zhang, J., Mardis, E. R., Pui, C.-H., Ding, L., Ley, T. J., & Evans, W. E. (2012) · Nature Genetics · doi:10.1038/ng.2287 · Cited by 377
Self-citationLong-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia
Schmiegelow, K., Forestier, E., Hellebostad, M., Heyman, M., Kristinsson, J., Söderhäll, S., Taskinen, M., & On behalf of the Nordic Society of Paediatric Haematology and Oncology (NOPHO) (2010) · Leukemia · doi:10.1038/leu.2009.251 · Cited by 365
Self-citationTreviño, L. R., Shimasaki, N., Yang, W., Panetta, J. C., Cheng, C., Pei, D., Chan, D., Sparreboom, A., Giacomini, K. M., Pui, C.-H., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.4156 · Cited by 349
Self-citationHertzberg, L., Vendramini, E., Ganmore, I., Cazzaniga, G., Schmitz, M., Chalker, J., Shiloh, R., Iacobucci, I., Shochat, C., Zeligson, S., et al. (2010) · Blood · doi:10.1182/blood-2009-08-235408 · Cited by 346
Self-citationBiondi, A., Schrappe, M., De Lorenzo, P., Castor, A., Lucchini, G., Gandemer, V., Pieters, R., Stary, J., Escherich, G., Campbell, M., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70377-7 · Cited by 330
Self-citationA recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia
Shah, S., Schrader, K. A., Waanders, E., Timms, A. E., Vijai, J., Miething, C., Wechsler, J., Yang, J., Hayes, J., Klein, R. J., et al. (2013) · Nature Genetics · doi:10.1038/ng.2754 · Cited by 327
Self-citationVrooman, L. M., Stevenson, K. E., Supko, J. G., O'Brien, J., Dahlberg, S. E., Asselin, B. L., Athale, U. H., Clavell, L. A., Kelly, K. M., Kutok, J. L., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.2070 · Cited by 315
Self-citationPerez-Andreu, V., Roberts, K. G., Harvey, R. C., Yang, W., Cheng, C., Pei, D., Xu, H., Gastier-Foster, J., E, S., Lim, J. Y.-S., et al. (2013) · Nature Genetics · doi:10.1038/ng.2803 · Cited by 305
Self-citationOutcome of treatment in children with hypodiploid acute lymphoblastic leukemia
Nachman, J. B., Heerema, N. A., Sather, H., Camitta, B., Forestier, E., Harrison, C. J., Dastugue, N., Schrappe, M., Pui, C.-H., Basso, G., et al. (2007) · Blood · doi:10.1182/blood-2006-07-038299 · Cited by 304
Self-citationVora, A., Goulden, N., Mitchell, C., Hancock, J., Hough, R., Rowntree, C., Moorman, A. V., & Wade, R. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70243-8 · Cited by 302
Self-citationvan der Veer, A., Waanders, E., Pieters, R., Willemse, M. E., Van Reijmersdal, S. V., Russell, L. J., Harrison, C. J., Evans, W. E., van der Velden, V. H. J., Hoogerbrugge, P. M., et al. (2013) · Blood · doi:10.1182/blood-2012-10-462358 · Cited by 289
Self-citationOutcomes after Induction Failure in Childhood Acute Lymphoblastic Leukemia
Schrappe, M., Hunger, S. P., Pui, C.-H., Saha, V., Gaynon, P. S., Baruchel, A., Conter, V., Otten, J., Ohara, A., Versluys, A. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110169 · Cited by 289
Self-citationDiouf, B., Crews, K. R., Lew, G., Pei, D., Cheng, C., Bao, J., Zheng, J. J., Yang, W., Fan, Y., Wheeler, H. E., et al. (2015) · JAMA · doi:10.1001/jama.2015.0894 · Cited by 278
Self-citationRare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition
Ramsey, L. B., Bruun, G. H., Yang, W., Treviño, L. R., Vattathil, S., Scheet, P., Cheng, C., Rosner, G. L., Giacomini, K. M., Fan, Y., et al. (2012) · Genome Research · doi:10.1101/gr.129668.111 · Cited by 261
Self-citationRoberts, K. G., Pei, D., Campana, D., Payne-Turner, D., Li, Y., Cheng, C., Sandlund, J. T., Jeha, S., Easton, J., Becksfort, J., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.4105 · Cited by 256
Self-citationVariation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk
Sherborne, A. L., Hosking, F. J., Prasad, R. B., Kumar, R., Koehler, R., Vijayakrishnan, J., Papaemmanuil, E., Bartram, C. R., Stanulla, M., Schrappe, M., et al. (2010) · Nature Genetics · doi:10.1038/ng.585 · Cited by 255
Self-citationBuitenkamp, T. D., Izraeli, S., Zimmermann, M., Forestier, E., Heerema, N. A., van den Heuvel-Eibrink, M. M., Pieters, R., Korbijn, C. M., Silverman, L. B., Schmiegelow, K., et al. (2014) · Blood · doi:10.1182/blood-2013-06-509463 · Cited by 248
Self-citationVeerman, A. J., Kamps, W. A., van den Berg, H., van den Berg, E., Bökkerink, J. P., Bruin, M. C., van den Heuvel-Eibrink, M. M., Korbijn, C. M., Korthof, E. T., van der Pal, K., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70228-1 · Cited by 245
Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements
Pui, C.-H., Chessells, J. M., Camitta, B., Baruchel, A., Biondi, A., Boyett, J. M., Carroll, A., Eden, O. B., Evans, W. E., Gadner, H., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2402883 · Cited by 241
Self-citationAricò, M., Schrappe, M., Hunger, S. P., Carroll, W. L., Conter, V., Galimberti, S., Manabe, A., Saha, V., Baruchel, A., Vettenranta, K., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.1325 · Cited by 240
Self-citationPatrick, K., Wade, R., Goulden, N., Mitchell, C., Moorman, A. V., Rowntree, C., Jenkinson, S., Hough, R., & Vora, A. (2014) · British Journal of Haematology · doi:10.1111/bjh.12882 · Cited by 233
Self-citationXu, H., Yang, W., Perez-Andreu, V., Devidas, M., Fan, Y., Cheng, C., Pei, D., Scheet, P., Burchard, E. G., Eng, C., et al. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt042 · Cited by 227
Self-citationTong, W. H., Pieters, R., Kaspers, G. J. L., te Loo, D. M. W. M., Bierings, M. B., van den Bos, C., Kollen, W. J. W., Hop, W. C. J., Lanvers-Kaminsky, C., Relling, M. V., et al. (2014) · Blood · doi:10.1182/blood-2013-10-534347 · Cited by 225
Self-citationYang, J. J. (2009) · JAMA · doi:10.1001/jama.2009.7 · Cited by 216
Self-citationWeston, B. W., Hayden, M. A., Roberts, K. G., Bowyer, S., Hsu, J., Fedoriw, G., Rao, K. W., & Mullighan, C. G. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.6770 · Cited by 213
Self-citationGenome-wide study of methotrexate clearance replicates SLCO1B1
Ramsey, L. B., Panetta, J. C., Smith, C., Yang, W., Fan, Y., Winick, N. J., Martin, P. L., Cheng, C., Devidas, M., Pui, C.-H., et al. (2013) · Blood · doi:10.1182/blood-2012-08-452839 · Cited by 208
Self-citationLengline, E., Beldjord, K., Dombret, H., Soulier, J., Boissel, N., & Clappier, E. (2013) · Haematologica · doi:10.3324/haematol.2013.095372 · Cited by 172
Pharmacogenetic Risk Factors for Osteonecrosis of the Hip Among Children With Leukemia
Relling, M. V., Yang, W., Das, S., Cook, E. H., Rosner, G. L., Neel, M., Howard, S., Ribeiro, R., Sandlund, J. T., Pui, C.-H., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.020 · Cited by 165
Self-citationMann, G., Attarbaschi, A., Schrappe, M., De Lorenzo, P., Peters, C., Hann, I., De Rossi, G., Felice, M., Lausen, B., LeBlanc, T., et al. (2010) · Blood · doi:10.1182/blood-2010-03-273532 · Cited by 164
Self-citationWang, X., Liu, W., Sun, C.-L., Armenian, S. H., Hakonarson, H., Hageman, L., Ding, Y., Landier, W., Blanco, J. G., Chen, L., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.50.3557 · Cited by 161
Self-citationMigliorini, G., Fiege, B., Hosking, F. J., Ma, Y., Kumar, R., Sherborne, A. L., da Silva Filho, M. I., Vijayakrishnan, J., Koehler, R., Thomsen, H., et al. (2013) · Blood · doi:10.1182/blood-2013-03-491316 · Cited by 160
Self-citationLugthart, S., Cheok, M. H., den Boer, M. L., Yang, W., Holleman, A., Cheng, C., Pui, C.-H., Relling, M. V., Janka-Schaub, G. E., Pieters, R., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.03.002 · Cited by 160
Self-citationKager, L., Cheok, M. H.-C., Yang, W., Zaza, G., Cheng, Q., Panetta, J. C., Pui, C., Downing, J. R., Relling, M. V., & Evans, W. E. (2005) · Journal of Clinical Investigation · doi:10.1172/jci22477 · Cited by 155
Self-citationA revised definition for cure of childhood acute lymphoblastic leukemia
Pui, C., Pei, D., Campana, D., Chen, C., Sandlund, J. T., Bowman, W. P., Hudson, M. M., Ribeiro, R. C., Raimondi, S. C., Jeha, S., et al. (2014) · Leukemia · doi:10.1038/leu.2014.142 · Cited by 147
Self-citationImproved Prognosis for Older Adolescents With Acute Lymphoblastic Leukemia
Pui, C., Pei, D., Campana, D., Bowman, W. P., Sandlund, J. T., Kaste, S. C., Ribeiro, R. C., Rubnitz, J. E., Coustan‐Smith, E., Jeha, S., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.0325 · Cited by 139
Self-citationYeoh, A. E. J., Ariffin, H., Chai, E. L. L., Kwok, C. S. N., Chan, Y. H., Kuperan, P., Campana, D., Tan, P. L., Chan, M. Y., Kham, S. K. Y., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.5936 · Cited by 135
Self-citationEllinghaus, E., Stanulla, M., Richter, G., Ellinghaus, D., Kronnie, G. T., Cario, G., Cazzaniga, G., Horstmann, M. A., Grümayer, R. P., Cavé, H., et al. (2011) · Leukemia · doi:10.1038/leu.2011.302 · Cited by 134
Self-citationDiouf, B., Cheng, Q., Krynetskaia, N. F., Yang, W., Cheok, M., Pei, D., Fan, Y., Cheng, C., Krynetskiy, E. Y., Geng, H., et al. (2011) · Nature Medicine · doi:10.1038/nm.2430 · Cited by 129
Self-citationHLA-DRB1*07:01 is associated with a higher risk of asparaginase allergies
Fernandez, C. A., Smith, C. J., Yang, W., Daté, M., Bashford, D., Larsen, E. C., Bowman, W. P., Liu, C., Ramsey, L. B., Chang, T. Y., et al. (2014) · Blood · doi:10.1182/blood-2014-03-563742 · Cited by 126
Self-citationGenomic Characterization of Childhood Acute Lymphoblastic Leukemia
Mullighan, C. G. (2013) · Seminars in Hematology · doi:10.1053/j.seminhematol.2013.10.001 · Cited by 123
Self-citationFrench, D., Hamilton, L. H., Mattano, L. A., Sather, H. N., Devidas, M., Nachman, J. B., & Relling, M. V. (2008) · Blood · doi:10.1182/blood-2007-11-123885 · Cited by 123
Self-citationSchmiegelow, K., Forestier, E., Kristinsson, J., Söderhäll, S., Vettenranta, K. K., Weinshilboum, R. M., Wesenberg, F., & On behalf of the Nordic Society of Paediatric Haematology and Oncology (NOPHO) (2008) · Leukemia · doi:10.1038/leu.2008.316 · Cited by 122
Self-citationBuitenkamp, T., Pieters, R., Gallimore, N. E., van der Veer, A., Meijerink, J. P. P., Beverloo, H. B., Zimmermann, M., de Haas, V., Richards, S. M., Vora, A. J., et al. (2012) · Leukemia · doi:10.1038/leu.2012.84 · Cited by 109
Self-citationTreanor, L. M., Zhou, S., Janke, L. J., Churchman, M. L., Ma, Z., Lu, T., Chen, S.-C., Mullighan, C. G., & Sorrentino, B. P. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20122727 · Cited by 105
Self-citationRichards, S. M., Pui, C., Gayon, P., & on behalf of the Childhood Acute Lymphoblastic Leukemia Collaborative Group (CALLCG) (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24228 · Cited by 98
Self-citationKawedia, J. D., Liu, C., Pei, D., Cheng, C., Fernandez, C. A., Howard, S. C., Campana, D., Panetta, J. C., Bowman, W. P., Evans, W. E., et al. (2011) · Blood · doi:10.1182/blood-2011-09-381731 · Cited by 95
Self-citationZwaan, C. M., Rizzari, C., Mechinaud, F. M., Lancaster, D. L., Lehrnbecher, T., van der Velden, V. H. J., Beverloo, B., den Boer, M. L., Pieters, R., Reinhardt, D., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.8280 · Cited by 95
Self-citationYeoh, A. E. J., Tan, D. C. L., Li, C. K., Hori, H., Tse, E., & Pui, C. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70452-2 · Cited by 95
Self-citationDomenech, C., Suciu, S., Moerloose, B. D., Mazingue, F., Plat, G., Ferster, A., Uyttebroeck, A., Sirvent, N., Lutz, P., Yakouben, K., et al. (2014) · Haematologica · doi:10.3324/haematol.2014.103507 · Cited by 81
Sorich, M. J., Pottier, N., Pei, D., Yang, W., Kager, L., Stocco, G., Cheng, C., Panetta, J. C., Pui, C., Relling, M. V., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050083 · Cited by 79
Self-citationKaryotypic abnormalities create discordance of germline genotype and cancer cell phenotypes
Cheng, Q., Yang, W., Raimondi, S. C., Pui, C., Relling, M. V., & Evans, W. E. (2005) · Nature Genetics · doi:10.1038/ng1612 · Cited by 77
Self-citationCRHR1 Polymorphisms Predict Bone Density in Survivors of Acute Lymphoblastic Leukemia
Jones, T. S., Kaste, S. C., Liu, W., Cheng, C., Yang, W., Tantisira, K. G., Pui, C., & Relling, M. V. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.6399 · Cited by 49
Self-citationPui, C.-H., Schrappe, M., Masera, G., Nachman, J. B., Gadner, H., Eden, O. B., Evans, W. E., & Gaynon, P. S. (2004) · Leukemia · doi:10.1038/sj.leu.2403365 · Cited by 48
Self-citationYamaji, K., Okamoto, T., Yokota, S., Watanabe, A., Horikoshi, Y., Asami, K., Kikuta, A., Hyakuna, N., Saikawa, Y., Ueyama, J., et al. (2010) · Pediatric Blood & Cancer · doi:10.1002/pbc.22620 · Cited by 39
Childhood Acute Lymphoblastic Leukaemia Collaborative Group (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07624.x · Cited by 35
Evidence for Age As a Modifier of Genetic Associations for Lipid Levels
Dumitrescu, L. C., Brown-Gentry, K. D., Goodloe, R., Glenn, K., Yang, W., Kornegay, N., Pui, C., Relling, M. V., & Crawford, D. C. (2011) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2011.00664.x · Cited by 33
Self-citationHunger, S. P., Baruchel, A., Biondi, A., Evans, W. E., Jeha, S., Loh, M. L., Moericke, A., Pieters, R., Relling, M. V., Schmiegelow, K., et al. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24354 · Cited by 8
Self-citation
Cited by
Top 10 Challenges in Cancer Immunotherapy
Hegde, P. S., & Chen, D. S. (2020) · Immunity · doi:10.1016/j.immuni.2019.12.011 · Cited by 2,238
The Different Mechanisms of Cancer Drug Resistance: A Brief Review
Mansoori, B., Mohammadi, A., Davudian, S., Shirjang, S., & Baradaran, B. (2017) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2017.041 · Cited by 1,883
Fry, T. J., Shah, N. N., Orentas, R. J., Stetler-Stevenson, M., Yuan, C. M., Ramakrishna, S., Wolters, P., Martin, S., Delbrook, C., Yates, B., et al. (2018) · Nature Medicine · doi:10.1038/nm.4441 · Cited by 1,335
Stock, W., Luger, S. M., Advani, A. S., Yin, J., Harvey, R. C., Mullighan, C. G., Willman, C. L., Fulton, N., Laumann, K. M., Malnassy, G., et al. (2019) · Blood · doi:10.1182/blood-2018-10-881961 · Cited by 488
Self-citationResults of NOPHO ALL2008 treatment for patients aged 1–45 years with acute lymphoblastic leukemia
Toft, N., Birgens, H., Abrahamsson, J., Griškevičius, L., Hallböök, H., Heyman, M., Klausen, T. W., Jónsson, Ó., Palk, K., Pruunsild, K., et al. (2018) · Leukemia · doi:10.1038/leu.2017.265 · Cited by 409
Self-citation
Metadata
- Authors
- Pui, C.-H., Yang, J. J., Hunger, S. P., Pieters, R., Schrappe, M., Biondi, A., Vora, A., Baruchel, A., Silverman, L. B., Schmiegelow, K., Escherich, G., Horibe, K., Benoit, Y. C. M., Izraeli, S., Yeoh, A. E. J., Liang, D.-C., Downing, J. R., Evans, W. E., Relling, M. V., & Mullighan, C. G.
- Venue
- Journal of Clinical Oncology
- Published
- 2015-09-20
- Volume
- 33
- Issue
- 27
- Pages
- 2938-2948
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2125277492
- Cited by
- 1,007
- References
- 89
- FWCI
- 66.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.